Abstract The abnormality of viral core structure seen in vif-defective HIV-1 grown in PBMCs has suggested a role for Vif in viral morphogenesis. Using an in vivo mammalian two-hybrid assay, the interaction between Vif and the precursor (Pr55 GAG ) of the virion nucleocapsid proteins has been analysed. This revealed the amino-terminal (aa 1-22) and central (aa 70-100) regions of Vif to be essential for its interaction with Pr55
Introduction
In addition to the canonical gag, pol and env genes found in all retroviruses, the human immunodeficiency virus (HIV-1), in common with most other lentiviruses, encodes six regulatory proteins (Tat, Rev, Vpr, Vif, Nef and Vpu) usually referred to as accessory proteins. Of these, Vif is encoded by all lentiviruses with the exception of equine infectious anaemia virus (EIAV) [29] , and in several animal models, it has been shown to be essential for virus infection [10, 17] . In HIV-1, Vif is a 23-kDa basic protein that is required in a cell-type-dependent fashion for the production of infectious virus [21] . Thus, most CD4
? continuous cell lines give normal virus yields when infected with vif-deleted virus and are consequently said to be permissive, whereas others, such as H9 cells and, crucially, PBMCs, the normal in vivo host cells for HIV, give greatly reduced virus yields of Vif-minus virus and are termed non-permissive or restrictive [12, 14, 15] . Studies on heterokaryons made between permissive and restrictive cells showed that the restrictive phenotype was dominant, indicating the presence in restrictive cells of an inhibitor of virus replication [25, 34] . In an elegant study, this inhibitor was identified as a member of the APOBEC family of cytidine deaminases [32] . A series of subsequent studies have shown that in the absence of Vif, APOBEC3G/3F expressed in restrictive cells is packaged into virus particles and leads to hypermutation of the viral genome following deamination of cytidine to uridine (C ? U) during synthesis of minus-strand viral cDNA [18, 26, 40, 41] . Despite the recent focus on the role of Vif in blocking the action of APOBEC, earlier studies on vifdeleted virus produced from restrictive cell lines revealed the virions to have malformed viral core structures, pointing to a possible role for Vif in modulating the processing by the viral protease of the Pr55 GAG precursor that leads to the formation of the viral nucleocapsid [4, 6, 19] . However, attempts to demonstrate a direct role for Vif in the morphogenesis of virus particles has produced conflicting results [5, 13] . In a previous study examining the sequence of the vif gene in virus isolated from patients undergoing treatment with antiviral drugs directed at the viral protease, we were able to show a linkage between specific amino acids at a number of positions in Vif and the development of resistance to protease inhibitors [1] . These data are again suggestive of a role for Vif in modulating the action of protease in processing of the Pr55 GAG precursor. In the present study we have made use of a mammalian two-hybrid assay [31, 37] to screen for direct interactions in vivo between Vif and both the viral protease and its substrate Pr55 GAG .
Materials and methods

Plasmids
The pM and pVP16 mammalian two-hybrid vectors from the 'Matchmaker TM ' system (Clontech) were used to generate fusion protein constructs for use in two-hybrid assays. Two reporter plasmids were employed: pG5CAT (Clontech), which expresses chloramphenicol acetyl transferase (CAT) under the control of a Gal4 responsive promoter, and pUAST-hrGFP-neo, which expresses green fluorescent protein (GFP), also under the control of a Gal4-responsive promoter. The latter plasmid was obtained from Dr. K.T. Chung (University of Warwick).
The vif sequences used in constructing two-hybrid fusion vectors were generated by PCR from a cDNA subclone carrying the vif gene generated from the HXB2 isolate of HIV-1 [7] . All cDNA clones whose derivation involved PCR were re-sequenced to ensure that no adventitious mutations had been introduced during PCR amplification. The coding sequence for Pr55 GAG was obtained by subcloning from a cDNA clone of the BH-10 isolate of HIV-1 [11] , and the coding sequence for the viral protease was also obtained by subcloning from a BH-10 derived DNA clone [2] .
Propagation and transfection of mammalian cells
The COS-1 line of African green monkey kidney cells [16] was used for all two-hybrid assays. The cells were grown in Glasgow modified MEM supplemented with 10% foetal calf serum. For use in transfection experiments, cells were plated in 12-well tissue culture dishes and used at *80% confluency. Each well of cells was transfected with a mixture containing 1 lg of each of the three plasmids and 3.5 ll of Lipofectamine 2000 (Invitrogen). In all experiments, cells were transfected in parallel with a plasmid expressing GFP constitutively from the immediate early promoter of cytomegalovirus to allow transfection efficiency to be measured so that comparability between experiments could be ensured.
Mammalian two-hybrid assays
Two reporter genes were employed in this study. GFP has the advantage that it can be simply assayed by UV microscopy of live cells, but its limitation is that it gives a largely qualitative plus-minus result. By contrast, the CAT reporter requires the preparation of cell extracts, and therefore assaying it is more labour-intensive but it has the advantage of giving a quantitative measure of reporter gene expression. Consequently, in most cases, interaction assays were initially scored using the GFP reporter, and then the strength of the interaction was assessed using the CAT reporter.
GFP expression was assayed in live cells by examining them under a UV microscope at 72 h after transfection. CAT reporter expression was assayed in cytoplasmic extracts of transfected cells also made at 72 h after transfection using an ELISA-based CAT assay kit from Roche as described in the manufacturer's instructions.
GST pulldown assays GST-Vif and GST-Pr55 GAG fusions used as 'bait' proteins in the assay were constructed by insertion of the relevant open reading frames into the pET42b vector (Novagen). After overnight induction of bait protein expression in E. coli (BLR) with 1 mM IPTG, cells were lysed using a French press, and a 30,000g supernatant containing the soluble GST fusions was prepared for binding to glutathione agarose beads for 6 h at 4°C. After washing extensively with phosphate-buffered saline (PBS) to remove unbound proteins, the beads were used in binding assays. Radiolabelled test proteins were prepared using the TNT Quick (Promega) coupled transcription-translation system according to the manufacturer's instructions. In all cases, the system was primed with a plasmid carrying the ORF of the test protein inserted downstream of the T7 promoter. 100,000 cpm of each test protein was incubated with either of the two bait proteins bound to glutathione beads in PBS-1% Triton-X-100 for 6 h at 4°C. After extensive washing with PBS-1% Triton X-100, the bound protein was eluted by boiling in 2% SDS-5% b-ME, and the retained radioactivity was measured by liquid scintillation counting.
Mutagenesis
Deletion and site-directed mutagenesis of the pVP16-Vif and pM-Pr55 GAG fusion vectors were both carried out using PCR-based techniques as described previously [20, 30] .
Results
Screening for in vivo interactions between Vif and Pr55
GAG or Protease (PR)
The GFP reporter was employed to provide a rapid and convenient assay for screening live cells for evidence of interaction between two-hybrid fusion constructs cotransfected into COS-1 cells. A clear interaction between Vif and Pr55 GAG was detected with fusion constructs of either protein to both the Gal4 DNA-binding domain and the VP16 activation domain (Fig. 1) . By contrast, no evidence of interaction between Vif and PR was seen with either of the PR fusion constructs generated ( Fig. 1 and results not shown). PR also failed to show any interaction with Pr55 GAG (Fig. 1 ).
The clear interaction between Vif and Pr55
GAG was confirmed in cell-free extracts made from cells co-transfected with the CAT reporter, which allowed a more quantitative assessment of the interaction (Fig. 2) .
Mapping the regions of Vif interacting with Pr55
GAG Initial attempts to localise the regions of Vif involved in the interaction with Pr55 GAG made use of three deletion mutants of Vif covering the amino-and carbox-terminal regions of the protein and a central region encompassing amino acids 70-100 (see Fig. 3 ). Two-hybrid assays carried out using these mutants revealed that both the amino-terminal 26 amino acids and the central region of the protein were essential for the interaction, whereas loss of the carboxy- 4 cells/well) were plated out in twelve-well tissue culture plates to give *80% confluent monolayers after overnight incubation at 37°C. These cells were co-transfected with the Gal4-responsive GFP reporter (pUAST-hrGFP-neo) plasmid and pM (Gal4 DNAbinding domain) and pVP16 (Gal4 activation domain) fusion constructs with Vif, Protease and Pr55 GAG as described in ''Materials and methods''. A positive control transfection in which cells were cotransfected with reporter plasmid and fusion constructs of p53 and large T from SV40, which are known to interact in mammalian cells, was included in all assays. The cell monolayers were examined by conventional light and UV microscopy 3 days after transfection and scored for reporter gene expression. Each of the figure consists of a pair of images, the left hand of which shows the cell monolayer controls (Fig. 4a) . The results shown in this and all other figures have been repeated on at least three occasions, and a complete set of illustrative results is shown in each case. In a previous study on Vif, we have reported on the importance of the conserved tryptophan (Trp) at amino acid 21 to the functioning of Vif to generate infectious virus when propagated in restrictive cell lines [7] . It was therefore of interest to examine the effect on Vif's interaction with Pr55 GAG of introducing the same mutational changes at amino acid 21 as those examined in the earlier studies. When this was done, there was a striking correspondence between results obtained in the two-hybrid assay and those found in the earlier study, in that changing the Trp 21 to arginine, isoleucine or tyrosine resulted in a greater than 80% drop in reporter gene expression, whereas substitution with phenyalanine gave wild-type levels of reporter gene activity (Fig. 4b) .
In an attempt to localise other regions of Vif that might contribute to its interaction with Pr55 GAG , attention was focused on the conserved BC-box motif, which has been shown to be crucial to the interaction of Vif with the Cul5-EloBC complex required to induce the ubiquitin-proteasome-based degradation of the APOBEC3G/3F viral inhibitor [28, 39] . Site-directed mutagenesis was employed to make single and double amino acid changes in the highly conserved YLAL region of this motif. However, when the mutated Vif was used in the two-hybrid assay, there was at most a 40% reduction in reporter gene expression (Fig. 4c) , indicating that this highly conserved motif is not essential for the Vif-Pr55 GAG interaction.
Mapping the regions of Pr55 GAG interacting with Vif
To begin the process of localising the region(s) of Pr55 GAG involved in interacting with Vif, a number of deletion mutants of the protein were constructed. These were focused primarily on the cleavage sites in the protein for the viral protease (see Fig. 3 ). The results obtained when these mutants were used in two-hybrid assays are shown in Table 1 . Deletion of either the amino-terminal or carboxyterminal 35 amino acids, deletion of L1 or deletion of L1 and SP1 from the carboxy terminus of the protein all had no effect on reporter gene expression. By comparison, if either the coding sequence for MA or a 35-amino-acid region encompassing the MA-CA junction was deleted, then reporter gene expression was reduced by [80% (Fig. 5) , indicating the importance of this region of Pr55 GAG for the interaction with Vif.
Validation of mammalian results using in vitro GST pull-down assay
To validate the protein interactions seen in vivo with the mammalian two-hybrid assay, a GST pull-down assay was used. The results obtained with this in vitro assay (Fig. 6 ) confirmed those obtained in vivo, with wild-type Vif and the Vif mutant with Phe replacing the Trp at position 21 both giving a clear interaction with Pr55 GAG . By contrast, the Tyr21 substitution of Vif caused the loss of Pr55 GAG interaction (Fig. 6) . The NSP1 protein of rotavirus, which is an RNA-binding protein, also failed to interact with Pr55 GAG in this assay (Fig. 6 ), making it unlikely that the observed Vif-Pr55 GAG interaction involved an RNA intermediate.
Discussion
The purpose of the present study was to extend a range of earlier studies [4-6, 13, 19] , including our own [1] , which have focused on a role for Vif in the process of viral morphogenesis. The mammalian two-hybrid assay used in Fig. 2 Analysis of the interaction between Vif and Pr55 GAG using a CAT reporter in the mammalian two-hybrid assay. COS-1 cells (*80% confluent) were co-transfected with the Gal4-responsive CAT reporter (pG5CAT) and various Vif and Pr55 GAG fusion constructs as indicated under each column of the bar chart using the construct abbreviations given in Fig. 3 . At 3 days post-transfection, the cell monolayers were harvested, and the level of reporter CAT expression was assayed in cell-free extracts using a CAT ELISA assay as described in ''Materials and methods''. The positive control used in these assays was co-transfection with fusion constructs expressing the interacting partners p53 and large T of SV40 virus. The negative control was co-transfection of cells with the two interaction plasmids carrying no fusion inserts this study provided clear evidence of an interaction between Vif and Pr55 GAG in vivo. This result is in line with an earlier, primarily in vitro study using a GST pull-down assay [5] . By contrast, no evidence of any interaction occurring between Vif and the protease of HIV-1 was found in the mammalian two-hybrid assay, which contradicts results obtained using ELISA assays with HIV proteins expressed in and purified from E. coli [3] . The negative result obtained in the mammalian two-hybrid assay does, however, need to be treated with some caution, as attempts to show an interaction between the viral protease and its substrate (Pr55 GAG ), which must occur if only transiently during virion assembly, were also unsuccessful.
The initial deletion analysis aimed at localising the region(s) of Vif involved in the interaction with Pr55 GAG showed that the amino-terminal region and a central area of Vif were both important for this interaction. By contrast, deletion of the carboxy-terminal 35 amino acids of Vif produced only a relatively small drop (*40%) in the level of interaction with Pr55 GAG , as measured by reporter gene expression in the mammalian two-hybrid assay. This last result is at odds with earlier results using the in vitro GST pull-down assay, where deletion of the carboxy-terminal 22 amino acids of Vif abolished its interaction with Pr55 GAG [5] . It seems probable that this discrepancy between the two studies can be attributed either to differences in the assay protocol (in vivo vs in vitro) and/or differences in the nature of the fusion partner employed (VP16 and Gal4 DNA-binding domain vs glutathione S transferase) and the effects that this may have on the properties of the fusion protein.
The initial deletion studies carried out on Pr55
GAG
showed that removal of 35 amino acids at the junction of MA (p17) and CA (p24) was sufficient to completely abolish the interaction with Vif, pointing to the main site of interaction lying in this region of the protein. This result is partially consistent with that found in the earlier in vitro study [5] in which the MA-CA junction was also identified as a region involved in interacting with Vif. However, the earlier study also identified a second site of interaction in the NC (p7) region of Pr55 GAG that was not found in the current study [5] . Again, this difference may be due to the detailed differences in both the constructs and assay protocols employed and should not at this stage be taken to indicate the presence of only one site of interaction between the two proteins in vivo.
Site-directed mutagenesis of Vif to more specifically localise regions of the protein involved in the interaction with Pr55
GAG revealed that the conserved tryptophan at position 21 was important. Changing this conserved position to arginine, isoleucine or tyrosine resulted in a greater than 80% drop in reporter gene expression in the twohybrid assay. By contrast, substitution of the tryptophan with phenylalanine had no effect on the Vif-Pr55 GAG interaction. These in vivo results were corroborated by similar findings in an in vitro GST pull-down assay. This is interesting in the context of our earlier work showing that these same mutational changes, when carried out on an infectious DNA clone of HIV, resulted in the same effects on the biological phenotype of virus produced in nonpermissive cells [7] . That is, substitution with arginine, isoleucine or tyrosine resulted in a Vif-minus phenotype, whereas substitution with phenylalanine gave a wild-type Vif phenotype [7] . More recent studies aimed at mapping the regions of Vif involved in overcoming the APO-BEC3G/3F-based inhibition of HIV replication have confirmed the importance of this conserved tryptophan [36] . This study further argued that Trp 21 mediated its effect on the APOBEC3G/3F inhibition by affecting the Vif-directed degradation of APOBEC3G/3F, although no data on Fig. 4 Mammalian two-hybrid analysis of Vif mutants to localise regions involved in interaction with Pr55 GAG . COS-1 cells (*80% confluent) were co-transfected with the Gal4-responsive CAT reporter (pG5CAT), a Pr55 GAG fusion construct in the pM Gal4 DNA-binding domain vector and various Vif fusion mutants with the designations given in Fig. 3 in the pVP16 activation domain vector. Negative controls in each case involved co-transfection of only the CAT reporter plasmid and Vif fusion under analysis. The specific plasmids used in each case are indicated under each column of the bar chart using the construct abbreviations given in Fig. 3 . At 3 days posttransfection, the cell monolayers were harvested, and the level of reporter CAT expression was assayed in cell-free extracts using a CAT ELISA assay as described in ''Materials and methods''. a Results for the deletion mutants of Vif generated using inverse PCR mutagenesis (IPCRM) as described in ''Materials and methods''. b Results for a series of point mutations of the conserved tryptophan at amino acid 21 of Vif. These mutations were generated using site-directed mutagenesis. c Results obtained by mutagenesis of the highly conserved YLAL residues that form part of the BC-box motif near the carboxy terminus of Vif. These mutations were generated using site-directed mutagenesis c degradation were presented for this specific tryptophan [36] . The results obtained on mutagenesis of the highly conserved YLAL residues that form part of the BC-box motif found towards the carboxy terminus of Vif were of interest in the context of the known involvement of this motif in APOBEC3G/3F degradation [28, 39] . Despite it having been shown to be crucial for the formation of the complex with Cul5-EloBC involved in targeting APO-BEC3G/3F for proteasome-based degradation [28, 39] , both single and double amino acid changes in the YLAL sequence had little or no effect on the Vif-Pr55 GAG interaction.
It has recently been shown that in the absence of functional Vif, APOBEC3G/3F will be incorporated into assembling viral capsids by interacting with the aminoterminal region of NC in Pr55 GAG [8, 24] . The confirmation in the present study that Vif also interacts in vivo with Pr55 GAG raises the speculative possibility that, in addition to its role in promoting the degradation of APOBEC3G/3F in non-permissive cells [9, 22, 23, 27, 33, 35, 38] , Vif may also directly compete with APOBEC3G/3F for incorporation into the assembling virus particle. If further studies aimed at mapping more precisely the binding sites for Vif on Pr55
GAG are able to confirm the earlier in vitro studies indicating that both proteins have interaction sites that involve the NC region of Pr55 GAG [5, 8, 24] , then it will be important to establish whether or not it is the effects that Vif may have on the incorporation of APOBEC3G/3F into assembling virions that represent its primary route to relieving the APOBEC-based block to HIV replication in normal host cells. [30] Mutants were tested for their interaction with wild-type (wt) Vif expressed as fusion with the VP16 activation domain using GFP and CAT as a reporter
Comparison of the expression of GFP or CAT reporter was done in relation to that given by a wild-type Pr55 GAG and wild-type Vif interaction, which was considered to be 100% (????) ???? = 100%;
??? = \75%; ?? = \50%; ? = \25%; -= 0% and ND = not done GAG fusion under analysis. The specific plasmids used in each case are indicated under each column of the bar chart using the construct abbreviations given in Fig. 3 . At 3 days post-transfection the cell monolayers were harvested, and the level of reporter CAT expression was assayed in cell-free extracts using a CAT ELISA assay as described in ''Materials and methods'' 
